Febuxostat Tablets — Class II drug recall D-0314-2024
Terminated recall by Amerisource Health Services LLC, reported 2024-02-14, distributed nationwide. CGMP Deviations
| Recall number | D-0314-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services LLC, Columbus, OH, United States |
| Recall initiated | 2024-01-25 |
| Classified | 2024-02-06 |
| Reported by FDA | 2024-02-14 |
| Terminated | 2025-12-22 |
| Distributed | Nationwide (US) |
| Quantity | 1,932 cartons |
| Reason classes | cgmp |
| NDC | 60687-0538, 60687-0538-11, 60687-0538-21 |
| Lot numbers | 1015033, 1016409 |
| Expiration dates | 2025-06-30, 2025-08-31 |
Product
Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-538-21, NDC Unit dose 60687-538-11
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0314-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.